Qualified kidney biomarkers and their potential significance in drug safety evaluation and prediction.
暂无分享,去创建一个
Shukui Wang | Hong-Guang Xie | Hong-Guang Xie | Ernie Harpur | Shu-Kui Wang | Chang-Chun Cao | E. Harpur | Hong‐Guang Xie | C. Cao
[1] J. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.
[2] B. Rosenzweig,et al. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. , 2011, Kidney international.
[3] M. Stonard,et al. Assessment of renal function and damage in animal species . A review of the current approach of the academic, governmental and industrial institutions represented by the animal clinical chemistry association , 1990, Journal of applied toxicology : JAT.
[4] A. Kribben,et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. , 2004, Clinical chemistry.
[5] C. Ponticelli,et al. Management of drug toxicity in patients with renal insufficiency , 2010, Nature Reviews Nephrology.
[6] D. Choudhury,et al. Drug-associated renal dysfunction and injury , 2006, Nature Clinical Practice Nephrology.
[7] Ronald P. Brown,et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[8] F. Di Maggio,et al. BIOMARKERS OF ACUTE RENAL INJURY AND RENAL FAILURE , 2006, Shock.
[9] L. Stevens,et al. Serum cystatin C as a marker of glomerular filtration rate , 2006, Current opinion in nephrology and hypertension.
[10] J. Bonventre. Kidney Injury Molecule‐1 (KIM‐1): A specific and sensitive biomarker of kidney injury , 2008, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[11] Joseph V Bonventre,et al. Next-generation biomarkers for detecting kidney toxicity , 2010, Nature Biotechnology.
[12] A. Grubb,et al. Renal handling of radiolabelled human cystatin C in the rat. , 1996, Scandinavian journal of clinical and laboratory investigation.
[13] Joseph V Bonventre,et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. , 2006, American journal of physiology. Renal physiology.
[14] Y. Sohn,et al. Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis , 2011, Pediatric Nephrology.
[15] R. Beyer,et al. Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether ("compound A") in rats. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[16] S. Pettit,et al. Evaluation of Novel Biomarkers of Nephrotoxicity in Two Strains of Rat Treated with Cisplatin , 2010, Toxicologic pathology.
[17] J Concato,et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. , 2008, Kidney international.
[18] Philip Hewitt,et al. Performance of novel kidney biomarkers in preclinical toxicity studies. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[19] G. D'Amico,et al. Pathophysiology of proteinuria. , 2003, Kidney international.
[20] S. Waikar,et al. Biomarkers for the diagnosis of acute kidney injury , 2007, Current opinion in nephrology and hypertension.
[21] G. Betton,et al. Application of Dolichos biflorus in immunoassay detection of kidney collecting duct biomarkers , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[22] C. Peck,et al. A roadmap for biomarker qualification , 2010, Nature Biotechnology.
[23] J. Bonventre,et al. Biomarkers of acute kidney injury. , 2008, Annual review of pharmacology and toxicology.
[24] P. H. Bach,et al. Renal Papillary Necrosis—40 Years On , 1998, Toxicologic pathology.
[25] Kazuo T. Suzuki,et al. Investigation on urinary proteins and renal mRNA expression in canine renal papillary necrosis induced by nefiracetam , 2005, Archives of Toxicology.
[26] N. Frangogiannis,et al. Biomarkers: hopes and challenges in the path from discovery to clinical practice. , 2012, Translational research : the journal of laboratory and clinical medicine.
[27] M. Shlipak,et al. Update on cystatin C: new insights into the importance of mild kidney dysfunction , 2006, Current opinion in nephrology and hypertension.
[28] J. Bonventre,et al. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. , 2008, Kidney international.
[29] B. Molitoris,et al. Controversies in nephrology: response to 'renal albumin handling, facts, and artifacts'. , 2007, Kidney international.
[30] W. Hiddemann,et al. Microalbuminuria during cisplatin therapy: relation with pharmacokinetics and implications for nephroprotection. , 2000, Anticancer research.
[31] J. Lewis,et al. Microalbuminuria in Type 2 Diabetes and Hypertension , 2008, Diabetes Care.
[32] A. Thompson. Proteinuria as a surrogate end point—more data are needed , 2012, Nature Reviews Nephrology.
[33] Joseph V Bonventre,et al. Biomarkers of nephrotoxic acute kidney injury. , 2008, Toxicology.
[34] Amy G. Aslamkhan,et al. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury , 2010, Nature Biotechnology.
[35] J. Bonventre,et al. Kidney Injury Molecule-1 ( Kim-1 ) : A Tissue and Urinary Biomarker for Nephrotoxicant-Induced Renal Injury . , 2003 .
[36] Timothy A Bertram,et al. Identification of putative gene based markers of renal toxicity. , 2004, Environmental health perspectives.
[37] R. Atkins,et al. Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis. , 2001, The American journal of pathology.
[38] Baolong Lu,et al. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] T. Skopek,et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function , 2010, Nature Biotechnology.
[40] Joseph V. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.
[41] M. Miyamoto,et al. Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats. , 2012, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[42] A. Durrbach,et al. Urinary cystatin C as a specific marker of tubular dysfunction , 2006, Clinical chemistry and laboratory medicine.
[43] A. Arısoy,et al. Acute effects of gentamicin on glomerular and tubular functions in preterm neonates , 2006, Pediatric Nephrology.
[44] V. Jeevanandam,et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. , 2008, Kidney international.
[45] N. Brunskill,et al. Thiazolidinediones Inhibit Albumin Uptake by Proximal Tubular Cells through a Mechanism Independent of Peroxisome Proliferator Activated Receptor Gamma , 2006, American Journal of Nephrology.
[46] M. Weber,et al. Alpha 1-microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction. , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[47] B. Molitoris,et al. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. , 2007, Kidney international.
[48] A. Kribben,et al. Early detection of acute renal failure by serum cystatin C. , 2004, Kidney international.
[49] M. Rosenberg,et al. Clusterin and the kidney. , 1995, Experimental nephrology.
[50] V. Dharnidharka,et al. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[51] Krishna Prasad,et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium , 2010, Nature Biotechnology.
[52] D. Gerhold,et al. Kidney Injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Multi-site Preclinical Biomarker Qualification Studies , 2010, Nature Biotechnology.
[53] G. Remuzzi,et al. Time to abandon microalbuminuria? , 2006, Kidney international.
[54] E. Lamb,et al. Alpha1-microglobulin is stable in human urine ex vivo. , 2002, Clinical chemistry.
[55] J. Westhuyzen. Cystatin C: a promising marker and predictor of impaired renal function. , 2006, Annals of clinical and laboratory science.
[56] Barry C. Jones,et al. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.
[57] E. Christensen,et al. Controversies in nephrology: renal albumin handling, facts, and artifacts! , 2007, Kidney international.
[58] G. Remuzzi,et al. Proteinuria should be used as a surrogate in CKD , 2012, Nature Reviews Nephrology.
[59] M. Perazella,et al. Drug-induced acute interstitial nephritis , 2010, Nature Reviews Nephrology.
[60] Syril Pettit,et al. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[61] S. Pennathur,et al. Marking renal injury: can we move beyond serum creatinine? , 2012, Translational research : the journal of laboratory and clinical medicine.
[62] Federico Goodsaid,et al. Evolution of biomarker qualification at the health authorities , 2010, Nature Biotechnology.
[63] M. Kuiper,et al. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy , 2010, Intensive Care Medicine.
[64] Frank D Sistare,et al. Research at the interface of industry, academia and regulatory science , 2010, Nature Biotechnology.
[65] Serafino Pantano,et al. Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury , 2010, Nature Biotechnology.
[66] A. Marshall,et al. Urinary Clusterin in Chronic Nephrotoxicity in the Rat , 1993, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[67] A. Gotoh,et al. Measurement of cystatin-C and creatinine in urine. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[68] N. Gretz,et al. Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries , 2002, Cell and Tissue Research.
[69] Frank D Sistare,et al. Towards consensus practices to qualify safety biomarkers for use in early drug development , 2010, Nature Biotechnology.
[70] John A Kellum,et al. Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.
[71] J. Kellum,et al. Epidemiology of acute kidney injury. , 2010, Contributions to nephrology.
[72] P. Cochat,et al. Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma , 1998, Pediatric Nephrology.
[73] Philip S Li,et al. Measurement of Urinary Clusterin as an Index of Nephrotoxicity , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[74] T. Uehara,et al. Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats. , 2010, Toxicology.
[75] Jonathan Himmelfarb,et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. , 2004, Kidney international.
[76] W. Comper,et al. Disease-dependent mechanisms of albuminuria. , 2008, American journal of physiology. Renal physiology.